Concept
Synthetic Lethality
Future of Cancer Science | AACR Cancer Progress Report 2025 / Drug Development
"Researchers have also developed a CRISPR screening platform to identify synthetic lethal interactions, which occur when two otherwise tolerated gene changes occur simultaneously and lead to cell death, across multiple cancer types. By pairing these results with large-scale drug sensitivity data from tumor cell line screens, they identified gene alterations that sensitize cancer cells to specific drugs, offering a systematic approach to match cancer patients with targeted therapies and advancing synthetic lethality-based treatment strategies (1070)Fong SH, et al. (2025) Nat Genet, 57:"
Related Ideas
- Drug DevelopmentFuture of Cancer Science | AACR Cancer Progress Report 2025 · Drug Development
- Target IdentificationFuture of Cancer Science | AACR Cancer Progress Report 2025 · Advancing New Treatments
- Drug DiscoveryFuture of Cancer Science | AACR Cancer Progress Report 2025 · Advancing New Treatments
- Clinical TestingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Gene EditingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Precision EditingFuture of Cancer Science | AACR Cancer Progress Report 2025 · Basic Research Discoveries
- Targeted DeliveryFuture of Cancer Science | AACR Cancer Progress Report 2025 · Next-Generation Treatments
- Clinical RelevanceFuture of Cancer Science | AACR Cancer Progress Report 2025 · Accelerating Basic Research Discoveries